Molecularly guided therapy improves survival outcomes for patients with a cancer of unknown primary

被引：0
|
作者：
Nierengarten, Mary Beth
机构：
来源：
CANCER | 2024年 / 130卷 / 24期
关键词：
D O I：
10.1002/cncr.35630
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Systemic therapy for cancer of unknown primary
    Zaun, Gregor
    Schuler, Martin
    ONKOLOGE, 2021, 27 (07): : 658 - 662
  • [12] Clinicopathologic features and survival outcomes of sarcomatoid carcinoma presenting as cancer of unknown primary.
    Huey, Ryan
    Makawita, Shalini
    Overman, Michael J.
    Ho, Linus
    Raghav, Kanwal Pratap Singh
    Varadhachary, Gauri R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [13] Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary
    Hauswald, Henrik
    Lindell, Katja
    Rochet, Nathalie
    Debus, Juergen
    Harms, Wolfgang
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (03) : 150 - 156
  • [14] Personalized molecularly matched therapies for carcinomas of unknown primary is associated with improved outcomes
    Adashek, J. J.
    Kato, S.
    Gumas, S.
    Lee, S.
    Okamura, R.
    Sicklick, J.
    Kurzrock, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S275 - S276
  • [15] Excision of primary tumour improves survival in metastatic breast cancer patients
    Pimentel, P.
    Perez-Fidalgo, J.
    Caballero, A.
    Pons, V.
    Martinez-Agullo, A.
    Bermejo, B.
    Barrera, J. A.
    Miranda, M. J.
    Lluch, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 273 - 273
  • [16] Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study
    Kraemer, Alwin
    Bochtler, Tilmann
    Pauli, Chantal
    Shiu, Kai-Keen
    Cook, Natalie
    de Menezes, Juliana Janoski
    Pazo-Cid, Roberto A.
    Losa, Ferran
    Robbrecht, Debbie G. J.
    Tomasek, Jiri
    Arslan, Cagatay
    Ozguroglu, Mustafa
    Stahl, Michael
    Bigot, Frederic
    Kim, Sun Young
    Naito, Yoichi
    Italiano, Antoine
    Chalabi, Nassera
    Duran-Pacheco, Gonzalo
    Michaud, Chantal
    Scarato, Jeremy
    Thomas, Marlene
    Ross, Jeffrey S.
    Moch, Holger
    Mileshkin, Linda
    LANCET, 2024, 404 (10452): : 527 - 539
  • [17] DRUG-THERAPY - TREATMENT OF PATIENTS WITH CANCER OF AN UNKNOWN PRIMARY SITE
    HAINSWORTH, JD
    GRECO, FA
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (04): : 257 - 263
  • [18] Neutrophil-to-lymphocyte ratio predicts survival in patients with cancer of unknown primary
    Talasiewicz, K.
    Czachowska, A.
    Omiotek, R.
    Wojcik, A.
    Kiliszczyk, A.
    Jagielska, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S727 - S727
  • [19] Survival in patients with cancer of unknown primary site (CUP): Mayo Clinic experience
    Suleiman, Riham
    Duran, Mayra
    Perneth, Sandra Algarin
    Torres, Ricardo Loor
    Jacome, Cristian Soto
    Gile, Jennifer
    Graham, Rondell P.
    Villasboas, Jose Caetano
    Leon-Ferre, Roberto Antonio
    Thome, Stephan
    Halfdanarson, Thorvardur Ragnar
    Bayne, Harry E. Fuentes
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [20] SURVIVAL AFTER THERAPY FOR CARCINOMA OF UNKNOWN PRIMARY (CUP)
    FISCHER, DS
    MARKHAM, LL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 389 - 389
12345